MAT2A program(Insilico Medicine Ltd)

N/A

Report date: 2023/08/03 15:01:18
NME

Base Information

Drug NameMAT2A program(Insilico Medicine Ltd)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionS-adenosylmethionine synthase isoform type-2 inhibitors
TargetsS-adenosylmethionine synthase isoform type-2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesInsilico Medicine Ltd
China Registration ClassN/A

Develop Information

Active CompaniesInsilico Medicine Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A